Literature DB >> 23381088

Helical peptides from VEGF and Vammin hotspots for modulating the VEGF-VEGFR interaction.

María Isabel García-Aranda1, Susana González-López, Clara María Santiveri, Nathalie Gagey-Eilstein, Marie Reille-Seroussi, Mercedes Martín-Martínez, Nicolas Inguimbert, Michel Vidal, María Teresa García-López, María Angeles Jiménez, Rosario González-Muñiz, María Jesús Pérez de Vega.   

Abstract

The design, synthesis, conformational studies and binding affinity for VEGF receptors of a collection of linear and cyclic peptide analogues of the N-terminal α-helix fragments 13-25 of VEGF and 1-13 of Vammin are described. Linear 13(14)-mer peptides were designed with the help of an AGADIR algorithm and prepared following peptide solid-phase synthetic protocols. Cyclic peptide derivatives were prepared on-resin from linear precursors with conveniently located Glu and Lys residues, by the formation of amide linkages. Conformational analysis, CD and NMR, showed that most synthesized peptides have a clear tendency to be structured as α-helices in solution. Some of the peptides were able to bind a VEGFR-1 receptor with moderate affinity. In addition to the described key residues (Phe17, Tyr21 and Tyr25), Val14 and Val20 seem to be relevant for affinity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381088     DOI: 10.1039/c3ob27312a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  7 in total

1.  Design of Anti-Angiogenic Peptidomimetics and Evaluation their Biological Activity by In Vitro Assays.

Authors:  Mona Ghadam; Soroush Sardari; Mohammad Ali Shokrgozar; Mahdiyeh Sadat Mahdavi
Journal:  Avicenna J Med Biotechnol       Date:  2020 Apr-Jun

2.  Disrupting VEGF-VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment.

Authors:  Beatriz Balsera; M Ángeles Bonache; Marie Reille-Seroussi; Nathalie Gagey-Eilstein; Michel Vidal; Rosario González-Muñiz; María Jesús Pérez de Vega
Journal:  Molecules       Date:  2017-10-28       Impact factor: 4.411

3.  Design and synthesis of C-terminal modified cyclic peptides as VEGFR1 antagonists.

Authors:  Lei Wang; Nathalie Gagey-Eilstein; Sylvain Broussy; Marie Reille-Seroussi; Florent Huguenot; Michel Vidal; Wang-Qing Liu
Journal:  Molecules       Date:  2014-09-26       Impact factor: 4.411

Review 4.  Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.

Authors:  Rosario González-Muñiz; María Ángeles Bonache; María Jesús Pérez de Vega
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

5.  Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors.

Authors:  Simone Zanella; Michele Mingozzi; Alberto Dal Corso; Roberto Fanelli; Daniela Arosio; Marco Cosentino; Laura Schembri; Franca Marino; Marta De Zotti; Fernando Formaggio; Luca Pignataro; Laura Belvisi; Umberto Piarulli; Cesare Gennari
Journal:  ChemistryOpen       Date:  2015-07-02       Impact factor: 2.911

6.  Structural Studies on an Anti-Angiogenic Peptide Using Molecular Modeling.

Authors:  Elham Assareh; Faramarz Mehrnejad; S Mohsen Asghari
Journal:  Iran J Biotechnol       Date:  2020-10-01       Impact factor: 1.671

7.  Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.

Authors:  Shunji Suetaka; Yoshiki Oka; Tomoko Kunihara; Yuuki Hayashi; Munehito Arai
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.